A Study of LY3007113 in Participants With Advanced Cancer

Clinical trial NCT01463631 · COMPLETED

Trial details

NCT number: NCT01463631
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Cancer

Start date: 2011-12-01
Primary completion: 2013-12-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.